SGS Institut Fresenius GmbH
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Im Maisel 14, Taunusstein, 65232, Germany (DEU)
- Operations here
- analysis
- FDA identifiers
- FEI 3003759588 · DUNS 317219699
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIVaccines and Allergenic Products2026-02-02
- VAIDrug Quality Assurance2025-02-21
- NAIDrug Quality Assurance2019-09-18
- NAIDrug Quality Assurance2014-09-19
- NAIDrug Quality Assurance2012-09-26
Drugs this plant is listed as making
4 distinct drugs across 14 products name this site in their FDA label.
- deferoxamine mesylateMitem Pharma
- macitentanActelion Pharmaceuticals US, Inc.
- SelexipagActelion Pharmaceuticals US, Inc.
- talazoparibU.S. Pharmaceuticals
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.